PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of kjtcsAims and ScopeInstructions to AuthorsE-SubmissionThis JournalThis Article
 
Korean J Thorac Cardiovasc Surg. 2016 June; 49(3): 195–198.
Published online 2016 June 5. doi:  10.5090/kjtcs.2016.49.3.195
PMCID: PMC4900863

Tricuspid Papillary Fibroelastoma Mimicking Tricuspid Vegetation in a Patient with Severe Neutropenia

Kuk Bin Choi, M.D., Hwan Wook Kim, M.D., Ph.D., Do Yeon Kim, M.D., Keon Hyon Jo, M.D., Ph.D., Hang Jun Choi, M.D., and Seok Beom Hong, M.D.

Abstract

We report a 72-year-old male with known myelodysplastic syndrome who presented to the emergency department with a 7-day history of fever and dyspnea. Echocardiography revealed a round echogenic mass 13×16 mm in size attached to the atrial side of the tricuspid valve. Considering the high risk of infective endocarditis in the patient with a low absolute neutrophil count (130/mm3), emergency surgery was performed. Intraoperatively, a single gelatinous neoplasm was resected, and subsequent reconstruction of the involved leaflet was accomplished using autologous pericardium. The tumor was pathologically confirmed as papillary fibroelastoma with no evidence of infective endocarditis. Papillary fibroelastoma is a rare cardiac neoplasm that occurs in either the mitral or aortic valves. Interestingly, a few cases of tricuspid valve papillary fibroelastoma have been reported so far. Similar echocardiographic findings between vegetation and tricuspid valve neoplasm make it difficult to distinguish these two disease entities.

Keywords: Heart neoplasms, Fibroelastoma, Tricuspid valve

CASE REPORT

A 72-year-old male with known myelodysplastic syndrome presented to of Seoul St. Mary’s Hospital with a 7-day history of fever and dyspnea. His planned chemotherapy for myelodysplastic syndrome had been stopped a month before due to fungal infection of the orbit. The initial absolute neutrophil count was only 130/mm3, and antibiotic therapy was initiated under the possibility of pneumonia or aggravation of orbital infection. Even after 7 days of antibiotic therapy, the fever persisted and no evidence of infection was found. We performed transthoracic echocardiography under suspicion of infective endocarditis; a 13 mm echogenic mass was found on the atrial side of the tricuspid valve (Fig. 1). Similar findings were also revealed by transesophageal echocardiography. Fortunately, no functional abnormalities of the valve were seen on echocardiography.

Fig. 1
Preoperative transthoracic echocardiogram shows an oscillating 13×16 mm echogenic mass which was attached on the atrial side of the tricuspid valve. RA, right atrium; RV, right ventricle; TV, tricuspid valve.

Based on the clinical symptoms and the echocardiographic findings, the patient was highly suspected of having infective endocarditis of the tricuspid valve. He was scheduled for emergency surgical removal due to the possibility of fungal endocarditis and the poor clinical course of infective endocarditis in immunocompromised patients. With a cardiopulmonary bypass, the right atrium was opened after aortic cross-clamping and cardioplegic arrest. On the exploration, a solitary polypoid gelatinous mass 13×16 mm in size infiltrating the septal leaflet of the tricuspid valve was found in the surgical field (Fig. 2). Although the tumor had a stalk, simple resection without making a defect in the septal leaflet appeared to be impossible, because the leaflet was too thin. Therefore, the mass was excised with part of the septal leaflet of the tricuspid valve using the quadrangular resection technique, followed by reconstruction with autologous pericardium. After successful weaning from the cardiopulmonary bypass, intraoperative transesophageal echocardiography was performed, showing no residual tumors. The tricuspid valve was found to be competent without any functional deficits after operation. Papillary fibroelastoma was pathologically confirmed, and no evidence of infective endocarditis was found (Fig. 3). Follow-up transthoracic echocardiography showed no residual or recurrent tumor, with uneventful postoperative recovery.

Fig. 2
Intraoperative finding shows the mass (arrow) attached to the septal leaflet of tricuspid valve without stalk. AO, aorta; SVC, superior vena cava; IVC, inferior vena cava.
Fig. 3
(A) Flower like appearance with multiple papillary fronds (gross). (B) Distinctive cluster of hair-like projections (H&E, ×40). (C) A central core of collagen surrounded by loose connective tissue, and covered by the endothelial cells ...

DISCUSSION

Primary cardiac tumor is very rare, and its frequency is approximately 0.02% according to the data from 22 autopsy cases [1]. Cardiac papillary fibroelastoma is the third most common benign primary cardiac neoplasm and the most common cardiac valvular tumor [2].

Grossly, cardiac papillary fibroelastoma is a gelatinous mass with multiple narrow papillary fronds, and it attaches to the endocardium via a short pedicle. Fibroelastoma is best visualized when immersed in water or saline. When the tumor is put in saline immediately after excision, it typically has a sea anemone-like appearance. The microscopic appearance is an avascular finger-like process with a core of elastin surrounded by collagen, which is covered by a single layer of endothelium [2,3]. The size of a cardiac papillary fibroelastoma varies from 2 to 70 mm, but the majority of tumors are approximately 10 mm in diameter [3]. The tumor is usually solitary, but rare cases of multiple cardiac papillary fibroelastoma have been reported [4]. Most of the tumors are located on the valvular surface, especially near or on the aortic valve (44%) and mitral valve (35%). Less frequently, the tumor infiltrates the pulmonary valve (8%) or the leaflets of the tricuspid valve (15%) [3].

The clinical presentation of a cardiac papillary fibroelastoma varies from no symptoms to severe thromboembolic complications, including transient ischemic attack, stroke, and myocardial infarction. Other complications include pulmonary embolism, congestive heart failure, near syncope, and sudden death. Cardiac papillary fibroelastoma occasionally manifests with fever, which abates after removal of the tumor [3]. Our patient with cardiac papillary fibroelastoma had a fever, which did not subside even after several days of antibiotic therapy. However, after surgical removal of the tumor, the fever disappeared during the hospital stay.

Transthoracic echocardiography is useful for initial evaluation of a suspected cardiac papillary fibroelastoma. Occasionally, a small cardiac papillary fibroelastoma may not be detected with transthoracic echocardiography; therefore, transesophageal echocardiography is required to further assess such a small tumor. Computed tomography and magnetic resonance imaging are also helpful in detecting cardiac papillary fibroelastoma, but their diagnostic accuracy is relatively low [5]. The mobility and location of the papillary fibroelastoma that has developed on the valvular surface can be misdiagnosed as infective vegetation. In comparison with cardiac papillary fibroelastoma, infective vegetation is usually associated with clinical signs of endocarditis and valvular destruction, and may resolve or change over a short period after treatment [3].

It is obvious that surgical excision is necessary in symptomatic patients with intracardiac tumors proven by echocardiography, regardless of the type and the location of tumors. Management of asymptomatic patients with cardiac papillary fibroelastoma is still controversial. However, when the tumor is a left-sided lesion, surgical excision is recommended due to high-risk thromboembolic events. Controversially, right-sided lesions are observed and surgically removed only in case they become symptomatic [6].

The risk of cardiac surgery in patients with hematologic malignancies remains to be established. Fecher et al. [7] demonstrated, in a study of 24 patients with hematologic malignancies undergoing cardiac surgery, that there was 1 in-hospital patient death (4.1%), 12 patients (50%) with a minor or major complication, and 7 patients requiring reoperations within 30 days due to bleeding, infection, and other clinical conditions. Chan et al. [8] reported, in a study of 26 patients with hematologic malignancies, that although there was no significant difference in mortality between patients with and without hematologic malignancies, there were significantly higher rates of transfusion, pneumonia, and sepsis in patients with hematologic malignancies than in patients without. The patient in this study improved after removal of the cardiac papillary fibroelastoma without any complications, and he is still alive at the 6-month follow-up.

Footnotes

This article was presented at the 23rd Annual Meeting of the Asian Society for Cardiovascular and Thoracic Surgery in 2015 as poster presentation.

CONFLICT OF INTEREST

No potential conflict of interest relevant to this article was reported.

REFERENCES

1. Reynen K. Frequency of primary tumors of the heart. Am J Cardiol. 1996;77:107. doi: 10.1016/S0002-9149(97)89149-7. [PubMed] [Cross Ref]
2. Patel J, Sheppard MN. Pathological study of primary cardiac and pericardial tumours in a specialist UK Centre: surgical and autopsy series. Cardiovasc Pathol. 2010;19:343–52. doi: 10.1016/j.carpath.2009.07.005. [PubMed] [Cross Ref]
3. Gowda RM, Khan IA, Nair CK, Mehta NJ, Vasavada BC, Sacchi TJ. Cardiac papillary fibroelastoma: a comprehensive analysis of 725 cases. Am Heart J. 2003;146:404–10. doi: 10.1016/S0002-8703(03)00249-7. [PubMed] [Cross Ref]
4. Seo HJ, Na CY, Yu JK. Multiple cardiac papillary fibroelastoma of the aortic valve. Korean J Thorac Cardiovasc Surg. 2008;41:496–8.
5. Kim JW, Jung JP, Shin JK, Park SE, Kim YM, Park CR. Papillary fibroelastoma of the aortic valve: discovered by chance with intraoperative transesophageal echocardiography: a case report. Korean J Thorac Cardiovasc Surg. 2007;40:637–40.
6. Anastacio MM, Moon MR, Damiano RJ, Jr, Pasque MK, Maniar HS, Lawton JS. Surgical experience with cardiac papillary fibroelastoma over a 15-year period. Ann Thorac Surg. 2012;94:537–41. doi: 10.1016/j.athoracsur.2012.04.006. [PMC free article] [PubMed] [Cross Ref]
7. Fecher AM, Birdas TJ, Haybron D, Papasavas PK, Evers D, Caushaj PF. Cardiac operations in patients with hematologic malignancies. Eur J Cardiothorac Surg. 2004;25:537–40. doi: 10.1016/j.ejcts.2003.12.006. [PubMed] [Cross Ref]
8. Chan J, Rosenfeldt F, Chaudhuri K, Marasco S. Cardiac surgery in patients with a history of malignancy: increased complication rate but similar mortality. Heart Lung Circ. 2012;21:255–9. doi: 10.1016/j.hlc.2012.02.004. [PubMed] [Cross Ref]

Articles from The Korean Journal of Thoracic and Cardiovascular Surgery are provided here courtesy of Korean Society for Thoracic and Cardiovascular Surgery